Disagree
Home Odin Pharma Odin Pharma
MK-2866
MK-2866 - Odin Pharma

MK-2866 - Odin Pharma

Brand:
Category:
Substance:
Dosage:
30 mg/tab
Package:
30 tablets
Price:
0
See options
Product Overview
Ostarine (MK-2866) was originally developed as a therapeutic agent to combat muscle loss associated with aging and chronic diseases. Its selective action on androgen receptors in muscle and bone makes it effective for muscle retention without the severe side effects of anabolic steroids. It is less androgenic, reducing the risk of acne, hair loss, and prostate enlargement. While Ostarine is considered safer, extended use can still suppress testosterone, requiring post-cycle therapy to normalize hormone levels.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about MK-2866 by Odin Pharma, consult with your doctor or healthcare professional.

Explore More Products
FAQ
How does Ostarine’s tissue selectivity work?
Ostarine selectively activates androgen receptors in muscle and bone without significant prostate or skin activation .
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What makes Ostarine different from other SARMs?
Ostarine exhibits a balanced profile of anabolic potency and safety, with extensive human trial data .
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Can Ostarine cause testosterone suppression?
At higher doses, Ostarine may weakly suppress the HPTA, sometimes requiring post-cycle support .
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.